Teacher Retirement System Of Texas Mersana Therapeutics, Inc. Transaction History

Teacher Retirement System Of Texas

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$1.06 - $3.91 $1,992 - $7,350	1,880 Added 8.47%	24,067 $31,000
Q2 2023 Jul 19, 2023	SELL	$3.08 - $9.55 $7,398 - $22,939	-2,402 Reduced 9.77%	22,187 $73,000
Q1 2023 May 12, 2023	BUY	$4.0 - $7.02 $3,908 - $6,858	977 Added 4.14%	24,589 $101,000
Q4 2022 Feb 10, 2023	SELL	$5.65 - $7.86 $10,746 - $14,949	-1,902 Reduced 7.45%	23,612 $138,000
Q3 2022 Nov 03, 2022	BUY	$4.63 - $8.0 $118,129 - $204,112	25,514 New	25,514 $172,000
Q2 2022 Aug 09, 2022	SELL	$2.84 - $5.0 $33,801 - $59,510	-11,902 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$3.74 - $6.63 $4,050 - $7,180	1,083 Added 10.01%	11,902 $47,000
Q4 2021 Feb 10, 2022	BUY	$5.48 - $9.86 $59,288 - $106,675	10,819 New	10,819 $67,000
Q2 2021 Aug 05, 2021	SELL	$13.28 - $18.07 $1.63 Million - $2.22 Million	-122,938 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$15.31 - $26.52 $217,447 - $376,663	-14,203 Reduced 10.36%	122,938 $1.99 Million
Q4 2020 Feb 11, 2021	SELL	$16.84 - $27.59 $16,099 - $26,376	-956 Reduced 0.69%	137,141 $3.65 Million
Q3 2020 Nov 02, 2020	BUY	$16.2 - $25.7 $2.24 Million - $3.55 Million	138,097 New	138,097 $2.57 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.